New York Life Trust’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$2K Buy
+13
New +$1.55K 0.1% 165
2015
Q4
Sell
-1,871
Closed -$184K 218
2015
Q3
$184K Sell
1,871
-69
-4% -$6.84K 0.82% 34
2015
Q2
$188K Buy
1,940
+775
+67% +$74.1K 0.78% 33
2015
Q1
$109K Buy
1,165
+1,112
+2,098% +$99.3K 0.43% 105
2014
Q4
$5K Buy
+53
New +$4.4K 0.02% 189
2013
Q4
Sell
-1,031
Closed -$76K 190
2013
Q3
$76K Buy
1,031
+198
+24% +$14.7K 0.38% 112
2013
Q2
$60K Buy
+833
New +$66.2K 0.28% 121

Other funds holding ACN

New York Life Trust's ACN Position: Q1 2017 in Review

New York Life Trust opened a new position in Accenture (ACN) in Q1 2017: 13 shares worth $2K. The stake represents 0.1% of the portfolio and ranks #165 among its holdings. This is a return to the name: New York Life Trust previously reported a position in ACN as recently as Q3 2015.

New York Life Trust first reported a position in ACN in Q2 2013 and has held it in 7 quarters since. The position peaked at $188K in Q2 2015. 1,075 funds tracked by Wall St. Rank hold ACN as of Q1 2017.

  • New York Life Trust held 13 shares of Accenture worth $2K as of Q1 2017.
  • Accenture was a new New York Life Trust position in Q1 2017.
  • Accenture made up 0.1% of New York Life Trust's portfolio in Q1 2017, its #165 holding.
  • New York Life Trust first reported a position in Accenture in Q2 2013 and has held it in 7 quarters since.
  • New York Life Trust's Accenture position peaked at $188K in Q2 2015.
  • 1,075 funds tracked by Wall St. Rank held Accenture as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.